...
tpst-img

Tempest Therapeutics Inc, Common Stock

TPST

NAQ

$0.8346

-$0.01

(-1.18%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$39.92M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
1.28M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-2.78
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.8 L
$6 H
$0.8346

About Tempest Therapeutics Inc, Common Stock

Tempest Therapeutics, Inc., a clinical-stage oncology company, develops small molecule therapeutics that combine both tumor-targeted and immune-mediated mechanisms to treat various tumors. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, which is in a Phase 1 trial to treat cancer; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial for the treatment of solid tumors. It also develops TREX-1, an enzyme that regulates cGAS/STING pathway signaling and immune recognition. The company has agreement with Roche to advance the evaluation of amezalpat (TPST-1120) in combination with atezolizumab (Tecentriq®) and bevacizumab. Tempest Therapeutics, Inc. was incorporated in 2011 and is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTPSTSectorS&P500
1-Week Return-4.85%-2.82%0.15%
1-Month Return-22.72%-4.22%1.78%
3-Month Return-37.25%-9.52%8.7%
6-Month Return-72.99%-3.45%12.24%
1-Year Return-75.67%5.62%30.9%
3-Year Return-88.74%3.8%30.19%
5-Year Return-99.11%39.68%91.72%
10-Year Return-99.99%105.02%203.2%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue1.05M815.00K1.27M1.81M381.00K[{"date":"2019-12-31","value":57.99,"profit":true},{"date":"2020-12-31","value":44.93,"profit":true},{"date":"2021-12-31","value":70.01,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":21,"profit":true}]
Gross Profit(1.05M)(815.00K)(1.27M)(1.81M)(381.00K)[{"date":"2019-12-31","value":-105200000,"profit":false},{"date":"2020-12-31","value":-81500000,"profit":false},{"date":"2021-12-31","value":-127000000,"profit":false},{"date":"2022-12-31","value":-181400000,"profit":false},{"date":"2023-12-31","value":-38100000,"profit":false}]
Gross Margin-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses44.35M19.30M26.99M34.64M29.16M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":43.52,"profit":true},{"date":"2021-12-31","value":60.85,"profit":true},{"date":"2022-12-31","value":78.11,"profit":true},{"date":"2023-12-31","value":65.75,"profit":true}]
Operating Income(45.40M)(19.30M)(26.99M)(34.64M)(29.16M)[{"date":"2019-12-31","value":-4539900000,"profit":false},{"date":"2020-12-31","value":-1929800000,"profit":false},{"date":"2021-12-31","value":-2698600000,"profit":false},{"date":"2022-12-31","value":-3464000000,"profit":false},{"date":"2023-12-31","value":-2915700000,"profit":false}]
Total Non-Operating Income/Expense-180.00K(2.60M)(2.69M)(1.84M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-1443.33,"profit":false},{"date":"2022-12-31","value":-1492.78,"profit":false},{"date":"2023-12-31","value":-1021.11,"profit":false}]
Pre-Tax Income(44.57M)(19.21M)(28.30M)(35.71M)(29.49M)[{"date":"2019-12-31","value":-4456800000,"profit":false},{"date":"2020-12-31","value":-1920800000,"profit":false},{"date":"2021-12-31","value":-2830200000,"profit":false},{"date":"2022-12-31","value":-3570900000,"profit":false},{"date":"2023-12-31","value":-2949100000,"profit":false}]
Income Taxes1.00K(90.00K)1.25M1.07M-[{"date":"2019-12-31","value":0.08,"profit":true},{"date":"2020-12-31","value":-7.21,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":85.66,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income After Taxes-(19.12M)(29.55M)(36.78M)-[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1911800000,"profit":false},{"date":"2021-12-31","value":-2955000000,"profit":false},{"date":"2022-12-31","value":-3677800000,"profit":false},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations-(19.21M)(28.30M)(35.71M)(31.11M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-1920800000,"profit":false},{"date":"2021-12-31","value":-2830200000,"profit":false},{"date":"2022-12-31","value":-3570900000,"profit":false},{"date":"2023-12-31","value":-3110600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(44.57M)(19.12M)(29.55M)(36.78M)(29.49M)[{"date":"2019-12-31","value":-4456800000,"profit":false},{"date":"2020-12-31","value":-1911800000,"profit":false},{"date":"2021-12-31","value":-2955000000,"profit":false},{"date":"2022-12-31","value":-3677800000,"profit":false},{"date":"2023-12-31","value":-2949100000,"profit":false}]
EPS (Diluted)(48.90)(29.10)(16.56)(3.26)(1.95)[{"date":"2019-12-31","value":-4890,"profit":false},{"date":"2020-12-31","value":-2910,"profit":false},{"date":"2021-12-31","value":-1656,"profit":false},{"date":"2022-12-31","value":-326,"profit":false},{"date":"2023-12-31","value":-195,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TPST
Cash Ratio 1.58
Current Ratio 1.69

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TPST
ROA (LTM) -54.28%
ROE (LTM) -289.26%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TPST
Debt Ratio Lower is generally better. Negative is bad. 0.66
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.34

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TPST
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.37
Price/FCF NM
EV/R 0.00
EV/Ebitda 0.31

FAQs

What is Tempest Therapeutics Inc share price today?

Tempest Therapeutics Inc (TPST) share price today is $0.8346

Can Indians buy Tempest Therapeutics Inc shares?

Yes, Indians can buy shares of Tempest Therapeutics Inc (TPST) on Vested. To buy Tempest Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TPST stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tempest Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Tempest Therapeutics Inc (TPST) via the Vested app. You can start investing in Tempest Therapeutics Inc (TPST) with a minimum investment of $1.

How to invest in Tempest Therapeutics Inc shares from India?

You can invest in shares of Tempest Therapeutics Inc (TPST) via Vested in three simple steps:

  • Click on Sign Up or Invest in TPST stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tempest Therapeutics Inc shares
What is Tempest Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Tempest Therapeutics Inc (TPST) is $6. The 52-week low price of Tempest Therapeutics Inc (TPST) is $0.8.

What is Tempest Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tempest Therapeutics Inc (TPST) is

What is Tempest Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tempest Therapeutics Inc (TPST) is 3.37

What is Tempest Therapeutics Inc dividend yield?

The dividend yield of Tempest Therapeutics Inc (TPST) is 0.00%

What is the Market Cap of Tempest Therapeutics Inc?

The market capitalization of Tempest Therapeutics Inc (TPST) is $39.92M

What is Tempest Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Tempest Therapeutics Inc is TPST

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top